VEGFR1 expression is related to lymph node metastasis and serum VEGF may be a marker of progression in the follow-up of patients with differentiated thyroid carcinoma

Karaca, Zahide; TANRIVERDİ, Fatih; ÜNLÜHİZARCI, KÜRŞAD; ÖZTÜRK, FİGEN; GÖKAHMETOĞLU, SELMA; Elbuken, Gülşah; Cakir, I.; BAYRAM, FAHRİ; Kelestimur, ZÜLEYHA

doi:10.1530/eje-10-0967

VEGFR1 expression is related to lymph node metastasis and serum VEGF may be a marker of progression in the follow-up of patients with differentiated thyroid carcinoma

Atıf İçin Kopyala

Karaca Z., TANRIVERDİ F., ÜNLÜHİZARCI K., ÖZTÜRK F., GÖKAHMETOĞLU S., Elbuken G., ...Daha Fazla

EUROPEAN JOURNAL OF ENDOCRINOLOGY, cilt.164, sa.2, ss.277-284, 2011 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 164 Sayı: 2
Basım Tarihi: 2011
Doi Numarası: 10.1530/eje-10-0967
Dergi Adı: EUROPEAN JOURNAL OF ENDOCRINOLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.277-284
Erciyes Üniversitesi Adresli: Evet

Özet

Objective: Vascular endothelial growth factor (VEGF) and VEGF receptor 1 (VEGFR1) are known to be related to thyroid tumorigenesis. The aim of the study was to examine the expressions and serum levels of VEGF, VEGFR1, IGF1, and IGF1 receptor (IGF1R) in patients with differentiated thyroid carcinoma (DTC) compared with patients with nodular goiter (NG).